Skip to main content
Equibles

Walleye Capital LLC

Position in TLRY — Tilray Brands, Inc.

CIK 1758720 NEW YORK, NY
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$26
+$26 QoQ
Shares Held
6
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#219
of 235 holders
Holding Since
Jun 2022
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Derivatives in TLRY

reported options exposure · as of Jun 30, 2026
CallValue
$2,103,565
CallShares
468,500
PutValue
$638,478
PutShares
142,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $47,294,180 across 23 Drug Manufacturers - Specialty & Generic names. TLRY ranks #21 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 165,410 $11,886,362
2 ANIP
Ani Pharmaceuticals Inc
 106,112 $8,783,951
3 BIOA
BioAge Labs, Inc.
 354,395 $8,686,221
4 XERS
Xeris Biopharma Holdings, Inc.
 611,296 $4,841,464
5 AMLX
Amylyx Pharmaceuticals, Inc.
 186,588 $3,351,120
6 ETON
Eton Pharmaceuticals, Inc.
 86,249 $3,122,213
7 EOLS
Evolus, Inc.
 253,817 $1,761,489
8 AQST
Aquestive Therapeutics, Inc.
 282,568 $1,175,482

All Filings in TLRY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,103,565 468,500
2026-06-30 $26 6
2026-06-30 $638,478 142,200
2026-03-31 $375,907 58,100
2026-03-31 $363,614 56,200
2025-12-31 $135 15
2025-12-31 $32,508 3,600
2025-12-31 $945,441 104,700
2024-03-31 $88,920 36,000
2023-03-31 $435,691 172,210
2022-06-30 $354,822 113,725